NCT00928746 - Actuation Indicator Trial in Patients With COPD | Biotech Hunter

Enrollment

142

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

August 31, 2009

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DEVICE

Ipratropium bromide

Trial Locations (7)

244.2507.0107 Boehringer Ingelheim Investigational Site, Lafayette

244.2507.0106 Boehringer Ingelheim Investigational Site, Easley

244.2507.0102 Boehringer Ingelheim Investigational Site, Gaffney

244.2507.0104 Boehringer Ingelheim Investigational Site, Greenville

244.2507.0105 Boehringer Ingelheim Investigational Site, Greenville

244.2507.0103 Boehringer Ingelheim Investigational Site, Spartanburg

244.2507.0101 Boehringer Ingelheim Investigational Site, Union